文献速递神经核医学

SV2A PET显像是检测实验性脊髓损伤模型脊髓损伤的无创标志物

SV2A PET Imaging Is a Noninvasive Marker for the Detection of Spinal Damage in Experimental Models of Spinal Cord Injury.
PubMed 文献 · J Nucl Med · 2022-01-13

本研究在实验性脊髓损伤(SCI)小鼠和大鼠模型中探索突触囊泡糖蛋白2A(SV2A)PET显像检测脊髓损伤的能力。结果显示损伤中心SV2A显著丢失,11C-UCB-J PET可无创检测到SV2A丢失并与尸检自显影相关,而18F-FDG PET仅显示轻微低代谢。作者认为SV2A PET可能为SCI提供客观测量工具并高度推荐临床评估使用。

要点

  • 小鼠和大鼠单侧中度颈髓(C5)挫伤后损伤中心SV2A显著丢失(-70.3%至-87.3%,P<0.0001)。
  • 11C-UCB-J PET在SCI大鼠检测到SV2A丢失(1周-49.0%±8.1%,6周-52.0%±12.9%),假手术组无变化。
  • 作者高度推荐SV2A PET显像用于SCI的临床评估。

核心结论

  • 11C-UCB-J PET/CT显像是SCI后SV2A丢失的无创标志物。
  • 这些发现表明SV2A PET可能提供SCI的客观测量,因而代表评估新疗法的有价值工具。
  • 作者高度推荐SV2A PET显像用于SCI的临床评估。

研究设计与样本

  • 对接受单侧中度颈髓(C5)挫伤的小鼠(n=7)和大鼠(n=8)在SCI后1周处死,进行组织学和放射自显影(3H标记UCB-J)研究SV2A水平。
  • 对假手术大鼠(n=7)和SCI大鼠(n=8)在SCI后1周和6周进行纵向11C-UCB-J PET/CT显像,并在后一时间点进行18F-FDG PET扫描。
  • SCI后6周进行死后组织SV2A分析以验证在体PET发现。

主要发现

  • 在小鼠和大鼠挫伤SCI模型的体外实验中,损伤中心测量到显著的SV2A丢失(范围-70.3%至-87.3%;P<0.0001)。
  • 纵向11C-UCB-J PET显像在SCI大鼠检测到SV2A丢失(SCI后1周-49.0%±8.1%,6周-52.0%±12.9%),假手术大鼠未见变化。
  • 相比之下,18F-FDG PET显像仅测量到轻微低代谢(-17.6%±14.7%)。
  • 死后3H-UCB-J放射自显影与在体SV2A PET发现相关(r=0.92,P<0.0001)。

临床怎么用

  • 作者高度推荐SV2A PET显像用于SCI的临床评估。
  • 作者认为SV2A PET可能提供SCI的客观测量,并代表评估新疗法的有价值工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Traumatic spinal cord injury (SCI) is a neurologic condition characterized by long-term motor and sensory neurologic deficits as a consequence of an external physical impact damaging the spinal cord. Anatomic MRI is considered the gold-standard diagnostic tool to obtain structural information for the prognosis of acute SCI; however, it lacks functional objective information to assess SCI progression and recovery. In this study, we explored the use of synaptic vesicle glycoprotein 2A (SV2A) PET imaging to detect spinal cord lesions noninvasively after SCI. Methods: Mice (n = 7) and rats (n = 8) subjected to unilateral moderate cervical (C5) contusion were euthanized 1 wk after SCI for histologic and autoradiographic (3H-labeled (4R)-1-[(3-methylpyridin-4-yl)methyl]-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one [UCB-J]) investigation of SV2A levels. Longitudinal 11C-UCB-J PET/CT imaging was performed in sham (n = 7) and SCI rats (n = 8) 1 wk and 6 wk after SCI. Animals also underwent an 18F-FDG PET scan during the latter time point. Postmortem tissue SV2A analysis to corroborate in vivo PET findings was performed 6 wk after SCI. Results: A significant SV2A loss (ranging from -70.3% to -87.3%; P < 0.0001) was measured at the epicenter of the impact in vitro in both mouse and rat contusion SCI models. Longitudinal 11C-UCB-J PET imaging detected SV2A loss in SCI rats (-49.0% ± 8.1% at 1 wk and -52.0% ± 12.9% at 6 wk after SCI), with no change observed in sham rats. In contrast, 18F-FDG PET imaging measured only subtle hypometabolism (-17.6% ± 14.7%). Finally, postmortem 3H-UCB-J autoradiography correlated with the in vivo SV2A PET findings (r = 0.92, P < 0.0001). Conclusion:11C-UCB-J PET/CT imaging is a noninvasive marker for SV2A loss after SCI. Collectively, these findings indicate that SV2A PET may provide an objective measure of SCI and thus represent a valuable tool to evaluate novel therapeutics. Clinical assessment of SCI with SV2A PET imaging is highly recommended.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bertoglio D, Halloin N, Lombaerde S, et al. SV2A PET Imaging Is a Noninvasive Marker for the Detection of Spinal Damage in Experimental Models of Spinal Cord Injury. J Nucl Med. 2022. PMID: 35027368. doi:10.2967/jnumed.121.263222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。